Restoring Normal Islet Mass and Function in Type 1 Diabetes through Regenerative Medicine and Tissue Engineering

The authors discuss the potential regenerative capacity of the remaining islet cells and the utility of stem cell-derived β-like cells to restore β-cell function and describe tissue engineering approaches that might improve the engraftment, function, and survival of β-cell replacement therapies.